HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
WGS
GeneDx Holdings Corp.
WGS lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
WGS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Strong |
WGS's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are weak.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
WGS PE Valuation
WGS has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 59x next year's earnings.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
WGS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
WGS has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
WGS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.88 | — |
| Q3 2026 | -$3.76 | -3518% |
| Q2 2026 | -$3.62 | -5271% |
| Q1 2026 | -$2.66 | -$1.27 |
| Q4 2025 | -$0.73 | +$1.21 |
| Q3 2025 | $0.11 | +$3.01 |
| Q2 2025 | $0.07 | +$4.30 |
| Q1 2025 | -$1.39 | +$3.58 |
| Q4 2024 | -$1.94 | +$5.29 |
WGS has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over WGS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over WGS on profitability, with a higher operating margin.
WGS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $123.1M | +5.4% |
| Q2 2026 | $114.4M | +11% |
| Q1 2026 | $102.3M | +17% |
| Q4 2025 | $121M | +27% |
| Q3 2025 | $116.7M | +52% |
| Q2 2025 | $102.7M | +46% |
| Q1 2025 | $87.1M | +40% |
| Q4 2024 | $95.6M | +67% |
WGS's revenue has grown year over year for 11 quarters in a row: $123M last quarter, up 5.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8.5% | -5.7 points |
| Q2 2026 | -15% | -24 points |
| Q1 2026 | -56% | -51 points |
| Q4 2025 | -12% | -21 points |
| Q3 2025 | -2.8% | +7.3 points |
| Q2 2025 | 8.7% | +24 points |
| Q1 2025 | -5.2% | +17 points |
| Q4 2024 | 9.2% | +54 points |
WGS's operating margin was −8.5% last quarter, down 5.7 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over WGS on cash generation, producing positive trailing cash flow while its opponent burns cash.
WGS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$15.8M | -265% |
| Q2 2026 | -$39.1M | -586% |
| Q1 2026 | -$38.9M | -1059% |
| Q4 2025 | -$7.4M | -$1.2M |
| Q3 2025 | $9.6M | +$14.6M |
| Q2 2025 | $8.1M | +$13.9M |
| Q1 2025 | $4.1M | +$20.9M |
| Q4 2024 | -$6.2M | +$26M |
WGS has burned cash in almost every quarter: −$101M over the past year, against $15M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over WGS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
WGS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +170K shares |
| 1 year | +3.8% | +1.1M shares |
| 3 years | +16% | +4.1M shares |
WGS has 30M diluted shares, up 3.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
WGS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -2.3x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
WGS has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
WGS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.6 | Neutral |
| Stochastic | 14.6 | Oversold |
WGS's weekly RSI is 40 (neutral) and its Stochastic is 15 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
WGS PE vs Healthcare Sector
| Metric | WGS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
WGS has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
WGS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $66.5 | 22% below |
| 20 week MA | $72.7 | 29% below |
| 50 week MA | $79.8 | 35% below |
| 100 week MA | $89.1 | 42% below |
| 200 week MA | $54.0 | 4% below |
WGS is in a downtrend: it's below all five of its weekly moving averages, and 4% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over WGS on returns for 2026, with the stronger performance.
WGS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $323.4 | $382.5 | +18% |
| 2021 | $382.5 | $154.1 | -60% |
| 2022 | $154.1 | $8.02 | -95% |
| 2023 | $8.02 | $2.75 | -66% |
| 2024 | $2.75 | $78.1 | +2738% |
| 2025 | $78.1 | $133.8 | +71% |
| 2026 YTD | $133.8 | $51.9 | -61% |
WGS's yearly returns have swung widely, from +2738% in 2024 to −95% in 2022. It's down 61% so far in 2026.